CAR-T Cell Therapy for Multiple Myeloma Market by Therapy Type :
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global CAR T-Cell Therapy for Multiple Myeloma - Market Snapshot
Chapter 4. Global CAR T-Cell Therapy for Multiple Myeloma - Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Clinical Trial/Pipeline Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Technology Advancement/Application Trends in CAR-T Cell Therapy
4.9. Incidence of Multiple Myeloma by Key Countries
4.10. Major Investment, Partnerships and Collaborations
4.11. Impact of COVID 19 on Immuno-oncology Industry
Chapter 5. Market Segmentation 1: Therapy Type Estimates & Trend Analysis
5.1. Therapy Type & Market Share, 2020 & 2030
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2018 to 2027 for the following Therapy Type:
5.2.1. Bb2121
5.2.2. JNJ-68284528 (LCAR-B38M)
5.2.3. P-BCMA-101
5.2.4. CAR-CD44V6
5.2.5. Others
Chapter 6. CAR T-Cell Therapy for Multiple Myeloma - Market Segmentation 3: Country/Region Estimates & Trend Analysis
6.1. The US
6.1.1. The US CAR T-Cell Therapy for Multiple Myeloma - Market revenue (US$ Million) estimates and forecasts by therapy type, 2020-2030
6.2. Germany
6.2.1. Germany CAR T-Cell Therapy for Multiple Myeloma - Market revenue (US$ Million) by therapy type, 2020-2030
6.3. France
6.3.1. France CAR T-Cell Therapy for Multiple Myeloma - Market revenue (US$ Million) by therapy type, 2020-2030
6.4. The UK
6.4.1. The UK CAR T-Cell Therapy for Multiple Myeloma - Market revenue (US$ Million) by therapy type, (US$ Million) 2020-2030
6.5. Italy
6.5.1. Italy revenue CAR T-Cell Therapy for Multiple Myeloma - Market revenue (US$ Million) by therapy type, (US$ Million) 2020-2030
6.6. Rest of World
6.6.1. Rest of World revenue CAR T-Cell Therapy for Multiple Myeloma - Market revenue (US$ Million) by therapy type, (US$ Million) 2020-2030
Chapter 7. Competitive Landscape
7.1. Major Mergers and Acquisitions/Strategic Alliances
7.2. Company Profiles
7.2.1. Bluebird bio/Celgene
7.2.2. Janssen Research & Development
7.2.3. Poseida Therapeutics
7.2.4. MolMed S.p.A.
7.2.5. Celgene Corporation
7.2.6. Cartesian Therapeutics
7.2.7. CARsgen Therapeutics
7.2.8. Precision BioSciences
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.